Article

Vision-Ease names finalists for award

Minneapolis, MN—Vision-Ease labs, a designer, manufacturer, and distributor of polycarbonate ophthalmic lenses, has named its 2004 Sun Rx Lab of the Year finalists: Homer Optical, Midland Optical, Select Optical, and VSP. Criteria for this award involved year over year of growth, introduction of the new SunRx Melanin, and support of the entire SunRx product line. The winner will be announced at Vision Expo East in New York City this month.

Minneapolis, MN-Vision-Ease labs, a designer, manufacturer, and distributor of polycarbonate ophthalmic lenses, has named its 2004 Sun Rx Lab of the Year finalists: Homer Optical, Midland Optical, Select Optical, and VSP. Criteria for this award involved year over year of growth, introduction of the new SunRx Melanin, and support of the entire SunRx product line. The winner will be announced at Vision Expo East in New York City this month.

Vision-Ease is kicking off its 2005 SunRx Rewards Program, which offers cash and prizes for supporting SunRx. Eye-care providers can earn $25 and 10 reward points for every five pairs of SunRx polycarbonate lenses they dispense.

Also, Vision-Ease recently partnered with SunStar Labs to promote SunRx at the Las Vegas Marathon and Fitness Expo. More than 25,000 people attended the 2-day Fitness Expo in February, making it a good opportunity for the companies to educate outdoor enthusiasts about the benefits of SunRx and SunRx Melanin polarized lenses.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.